http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105596788-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105596788-B |
| titleOfInvention | A kind of preparation method preventing and treating cerebrovascular disease medicament preparation |
| abstract | The present invention is a kind of pharmaceutical preparation and preparation method thereof for preventing and treating cranial vascular disease, it after Rhizoma Gastrodiae, Cortex Eucommiae processed, wild aconite root, radix aconiti lateralis preparata, Radix Angelicae Pubescentis, rhizoma ligustici, radix scrophulariae, Radix Angelicae Sinensis, glutinous rehmannia, radix cyathulae, mistletoe, the extracted purification of Rhizoma Et Radix Notopterygii by adding appropriate amount of auxiliary materials to be prepared；Drug of the invention has suppressing hyperactive liver for calming endogenous wind, cold dispelling of invigorating blood circulation, relaxing muscles and tendons analgesic efficacy, it is mainly used for ischemic cerebrovascular disease caused by liver yang causing wind, Cold-dampness and sees that tendon and vessel takes along pain, extremity numbness, inconvenient walking, waist and leg ache, headache and dizziness are looked dull, the treatment of the diseases such as dysphonia.Compared with prior art, the present invention is to extract effective parts formulation, and purity is high, taking dose is small, and bioavilability is high, and quality is stablized, and curative effect is more excellent, and toxicity is low, and safety is more preferable. |
| priorityDate | 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.